|
Volumn 94, Issue 7, 1987, Pages 620-635
|
Long‐term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy
a,c a,c a,d b |
Author keywords
[No Author keywords available]
|
Indexed keywords
CONJUGATED ESTROGEN;
ESTRADIOL;
ESTRADIOL VALERATE;
ESTRADIOL VALERATE PLUS LEVONORGESTREL;
ESTRADIOL VALERATE PLUS NORGESTREL;
ESTROGEN;
ETHINYLESTRADIOL;
GESTAGEN;
MESTRANOL;
NORETHISTERONE;
NORGESTREL;
PIPERAZINE ESTRONE SULFATE;
TESTOSTERONE;
UNCLASSIFIED DRUG;
ADVERSE DRUG REACTION;
BREAST;
BREAST CANCER;
CANCER INCIDENCE;
CARCINOGENESIS;
CHEMICAL CARCINOGENESIS;
DRUG THERAPY;
ENDOCRINE SYSTEM;
ENDOMETRIUM CANCER;
EPIDEMIOLOGY;
FEMALE GENITAL SYSTEM;
HORMONAL THERAPY;
HUMAN;
MAJOR CLINICAL STUDY;
MENOPAUSE;
MORTALITY;
OVARY CANCER;
PRIORITY JOURNAL;
SUICIDE;
THERAPY;
BREAST NEOPLASMS;
CARDIOVASCULAR DISEASES;
CERVIX NEOPLASMS;
FEMALE;
HORMONES, SYNTHETIC;
HUMAN;
MENOPAUSE;
MIDDLE AGE;
OVARIAN NEOPLASMS;
RISK;
SEX HORMONES;
SUICIDE;
SUPPORT, NON-U.S. GOV'T;
TIME FACTORS;
UTERINE NEOPLASMS;
|
EID: 0023177019
PISSN: 14700328
EISSN: 14710528
Source Type: Journal
DOI: 10.1111/j.1471-0528.1987.tb03166.x Document Type: Article |
Times cited : (257)
|
References (28)
|